Patents by Inventor Eduardo Dunayevich

Eduardo Dunayevich has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10259877
    Abstract: The present invention relates to methods of migraine prophylaxis using anti-CGRP receptor antibodies or binding fragments. In particular, methods for preventing or reducing the occurrence of migraine headache in a patient in need thereof comprising administering to the patient an anti-CGRP receptor or binding fragment according to specific dosage regimens are disclosed. Pharmaceutical compositions and administration devices comprising anti-CGRP receptor antibodies or binding fragments for use in the methods are also described.
    Type: Grant
    Filed: April 22, 2016
    Date of Patent: April 16, 2019
    Assignee: AMGEN INC.
    Inventors: Hong Sun, Eduardo Dunayevich, Robert A. Lenz, Gabriel Vargas
  • Publication number: 20160311913
    Abstract: The present invention relates to methods of migraine prophylaxis using anti-CGRP receptor antibodies or binding fragments. In particular, methods for preventing or reducing the occurrence of migraine headache in a patient in need thereof comprising administering to the patient an anti-CGRP receptor or binding fragment according to specific dosage regimens are disclosed. Pharmaceutical compositions and administration devices comprising anti-CGRP receptor antibodies or binding fragments for use in the methods are also described.
    Type: Application
    Filed: April 22, 2016
    Publication date: October 27, 2016
    Applicant: AMGEN INC.
    Inventors: Hong SUN, Eduardo DUNAYEVICH, Robert A. LENZ, Gabriel VARGAS
  • Publication number: 20160143903
    Abstract: Disclosed are methods of providing weight loss therapy, particularly for patients suffering from major depression.
    Type: Application
    Filed: January 29, 2016
    Publication date: May 26, 2016
    Inventors: Eduardo Dunayevich, Gary D. Tollefson
  • Patent number: 9248123
    Abstract: Disclosed are methods of providing weight loss therapy, particularly for patients suffering from major depression.
    Type: Grant
    Filed: January 10, 2011
    Date of Patent: February 2, 2016
    Assignee: Orexigen Therapeutics, Inc.
    Inventors: Eduardo Dunayevich, Gary Tollefson, David Dewitt
  • Publication number: 20130252995
    Abstract: Compositions, uses, kits and methods for reducing binge or compulsive eating are described herein. Methods may include administering an effective combination of a dosage of a bupropion or a pharmaceutically acceptable salt thereof, and a dosage of naltrexone or a pharmaceutically acceptable salt thereof. Methods may include identifying a patient who is overweight or obese and providing an effective combination of bupropion and naltrexone to the patient. Methods may include reducing a number of binge or compulsive eating events. Methods may include reducing severity of binge or compulsive eating events.
    Type: Application
    Filed: December 2, 2011
    Publication date: September 26, 2013
    Applicant: OREXIGEN THERAPEUTICS, INC.
    Inventors: Eduardo Dunayevich, Susan Mcelroy, Ron Landbloom
  • Publication number: 20130245056
    Abstract: Disclosed are compositions, uses, methods and kits for increasing drug bioavailability in a naltrexone therapy.
    Type: Application
    Filed: December 2, 2011
    Publication date: September 19, 2013
    Applicant: Orexigen Therapeutics, Inc.
    Inventors: Shawn Flanagan, Eduardo Dunayevich
  • Publication number: 20110172260
    Abstract: Disclosed are methods of providing weight loss therapy, particularly for patients suffering from major depression.
    Type: Application
    Filed: January 10, 2011
    Publication date: July 14, 2011
    Applicant: Orexigen Therapeutics, Inc.
    Inventors: Eduardo Dunayevich, Gary Tollefson, David Dewitt